Should we reduce dosing frequency in Biologic responders: Pros and Cons?

.ical

09-11, 17:30–18:00 (Europe/Istanbul), Rhinology 1 (ICC - B2 level BEYAZIT)

Valerie Hox

This speaker also appears in:

• BIOLOGICS IN ALLERGIC RHINITIS , WHAT CHANGED IN TREATMENT

Sietze Reitsma

This speaker also appears in:

• Personalizing therapy in CRS: From Cytokins to clinical choices
• Real world evidence in biological therapy for CRSwNP: Current status in 2026
• What's New in CRS? Updates from Recent Clinical Trials and Consensus Statements
• CSR Pathophysiology Update 2026

David Liu

This speaker also appears in:

• Quality of life after skull base surgery: Are we doing well?
• CRS outcomes and disease control – Are we doing well?
• The Principles of FESS: A Step-by-Step Guide for the Novice